Skip to main content

Table 4 Demographic, biochemical and clinical characteristics of diabetic patients when they divided into 3 categories based on their c-peptide concentrations

From: Screening for celiac disease in poorly controlled type 2 diabetes mellitus: worth it or not?

 

1st group

(n:13)

2nd group

(n:22)

3rd group

(n:66)

 
 

Mean

SD

Mean

SD

Mean

SD

p-value

Age (yrs)

53.38

5.28

56.64

6.06

54.08

8.79

0.362

SBP (mmHg)

126.15

17.58

127.62

11.36

130.00

16.13

0.647

DBP (mmHg)

77.69

12.35

79.29

7.79

80.94

10.19

0.518

BMI (kg/m2)

28.54

4.43

29.86

4.07

34.45

16.47

0.210

WC (cm)

95.85

15.85

101.50

7.80

103.53

14.04

0.168

Duration of Diabetes (yrs)

14.77

9.79

13.82

6.10

11.02

6.86

0.108

Total Insulin Dose (u)

54.46

25.09

62.10

34.98

53.76

27.59

0.535

tTGA IgA (U/mL)

36.44

88.13

5.15

6.39

4.57

4.64

0.004

hsCRP

5.20

8.60

6.74

5.63

7.85

7.63

0.579

FPG

227.69

153.26

200.00

66.04

217.89

71.14

0.591

PBG

274.71

128.90

322.21

88.55

304.83

80.31

0.506

HbA1c

10.13

2.08

10.69

1.93

9.69

1.70

0.080

C-peptide

0.24

0.20

0.78

0.14

2.18

1.01

<.0001

  1. The first group consists of patients with c-peptide level (normal range:0.51–2.7 ng/mL) lower than 0.51 ng/mL, the second group consists of patients with a c-peptide level between 0.51–1.0 ng/m L and third group consist of a c-peptide level higher than 1.0 ng/mL